EP4038060
DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
30.9.2020EP published:
15.11.2023EP application number:
20789680.4
EPO information:
European Patent Register
Max expiry date:
29.9.2040
Title in English:
DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORLanguage of the patent:
English
Timeline
Today
30.9.2020EP application
15.11.2023EP Publication
Owner
Name:
Pfizer Inc.Address:
66 Hudson Boulevard East, New York, NY 10001-2192, US
Inventor
Name:
EDMONDS, David JamesAddress:
Cambridge, Massachusetts 02139, US
Name:
FILIPSKI, Kevin JamesAddress:
Cambridge, Massachusetts 02139, US
Name:
FUTATSUGI, KentaroAddress:
Cambridge, Massachusetts 02139, US
Name:
GARNSEY, Michelle ReneeAddress:
Cambridge, Massachusetts 02139, US
Name:
LEE, Jack Chang HungAddress:
Groton, Connecticut 06340, US
Name:
SMALTZ, Daniel JonathanAddress:
Cambridge, Massachusetts 02139, US
Priority
Number:
201962911094 PDate:
4.10.2019Country:
US
Number:
202063074123 PDate:
3.9.2020Country:
US
Classification
Categories:
C07D 401/14, A61P 3/00, A61K 31/506